CLOs on the Move

South Georgia Medical Center

www.sgmc.org

 
South Georgia Medical Center is a not-for-profit, regional referral hospital dedicated to being the leader in improving the health, wellness and quality of life in the communities it serves. Located in the metropolis of Valdosta, Georgia, SGMC serves a multi-county area in South Georgia and North Florida. As a full-service, acute care hospital, SGMC provides area residents with broad services through our growing medical staff of more than 300 physicians and 3000 staff. Both of which are educated on the latest medical and surgical procedures, using the best technology to diagnose and treat patients and provide excellent patient care and ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.sgmc.org
  • 2501 North Patterson Street
    Valdosta, GA USA 31602
  • Phone: 229.333.1000

Executives

Name Title Contact Details

Similar Companies

Pediatric Home Services

We are dedicated to quality service for the medically fragile child. We service our patients based on each child's specific needs to develop their potential through clinical education and technical support. We believe it takes more than health care to

Honor

Honor provides personalized home care for people who want to continue to live in the homes they love—safely and happily—as they age.

LaBEX of MA

LaBEX of MA is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care Products Inc

Care Products Inc is a Waterbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.